Impacto de la obesidad en la función inmunitaria y el trastorno depresivo: revisión integradora
DOI:
https://doi.org/10.25118/2763-9037.2023.v13.631Palabras clave:
trastorno depresivo, sistema inmunológico, obesidad, inflamación, citocinasResumen
Objectivo: Esta revisión integradora tiene como objetivo buscar y analizar la evidencia científica sobre la relación entre obesidad, función inmune y trastorno depresivo. Métodos: El presente estudio es una revisión descriptiva de la literatura relativa a las palabras clave: obesidad, depresión, inmunológico, inflamación, psiconeuroinmunología y citocinas. Los critérios de inclusion fueron: artículos publicados en inglés; artículos referentes a la revisión integrativa y artículos publicados e indexados en la base de datos PubMed en los últimos 17 años. Resultados: Una gran cantidad de pruebas indica que la función inmunitaria parece estar comprometida en la obesidad y está relacionada con los síntomas depresivos. Sin embargo, aún se necesitan más pruebas para dilucidar mejor los componentes fisiológicos de la etiología de las incidencias depresivas a través de la obesidad y las alteraciones inmunológicas asociadas. Conclusiones: El escenario fisiopatológico de la obesidad está estrechamente relacionado con los cambios en la función inmunitaria y éstos pueden promover el desencadenamiento de síntomas depresivos a través de diversos mecanismos fisiológicos y, por tanto, repercutir negativamente en el estado de salud mental.
Descargas
Citas
Uher R, Payne JL, Pavlova B, Perlis RH. Major depressive disorder in DSM-5: implications for clinical practice and research of changes from DSM-IV. Depress Anxiety. 2014;31(6):459-71. https://doi.org/10.1002/da.22217 - PMID:24272961
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789-858. https://doi.org/10.1016/S0140-6736(18)32279-7 PMID:30496104
Jaacks LM, Vandevijvere S, Pan A, McGowan CJ, Wallace C, Imamura F, Mozaffarian D, Swinburn B, Ezzati M. The obesity transition: stages of the global epidemic. Lancet Diabetes Endocrinol. 2019;7(3):231-40. https://doi.org/10.1016/S2213-8587(19)30026-9 - PMID:30704950
Cordain L, Eaton SB, Sebastian A, Mann N, Lindeberg S, Watkins BA, O'Keefe JH, Brand-Miller J. Origins and evolution of the western diet: health implications for the 21st century. Am J Clin Nutr. 2005;81(2):341-54. https://doi.org/10.1093/ajcn.81.2.341 - PMID:15699220
Heredia FP, Gómez-Martínez S, Marcos A. Obesity, inflammation and the immune system. Proc Nutr Soc. 2012;71(2):332-8. https://doi.org/10.1017/S0029665112000092 - PMID:22429824
Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BWJH, Zitman FG. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010;67(3):220-9. https://doi.org/10.1001/archgenpsychiatry.2010.2 - PMID:20194822
Jantaratnotai N, Mosikanon K, Lee Y, McIntyre RS. The interface of depression and obesity. Obes Res Clin Pract. 2017;11(1):1-10. https://doi.org/10.1016/j.orcp.2016.07.003 - PMID:27498907
Shivappa N, Hébert JR, Veronese N, Caruso MG, Notarnicola M, Maggi S, Stubbs B, Firth J, Fornaro M, Solmi M. The relationship between the dietary inflammatory index (DII®) and incident depressive symptoms: a longitudinal cohort study. J Affect Disord. 2018;235:39-44. https://doi.org/10.1016/j.jad.2018.04.014 - PMID:29649709
Firth J, Marx W, Dash S, Carney R, Teasdale SB, Solmi M, Stubbs B, Schuch FB, Carvalho AF, Jacka F, Sarris J. The effects of dietary improvement on symptoms of depression and anxiety: a meta-analysis of randomized controlled trials. Psychosom Med. 2019;81(3):265-80. https://doi.org/10.1097/PSY.0000000000000673 - PMID:30720698 - PMCID:PMC6455094
Hamer M, Batty GD, Kivimaki M. Risk of future depression in people who are obese but metabolically healthy: the english longitudinal study of ageing. Mol Psychiatry. 2012;17:940-5. https://doi.org/10.1038/mp.2012.30 - PMID:22525487 - PMCID:PMC3428506
Hryhorczuk C, Sharma S, Fulton SE. Metabolic disturbances connecting obesity and depression. Front Neurosci. 2013;7:177. https://doi.org/10.3389/fnins.2013.00177 PMID:24109426 PMCID:PMC3791387
Park HS, Park JY, Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract. 2005;69(1):29-35. https://doi.org/10.1016/j.diabres.2004.11.007 - PMID:15955385
Hermsdorff HHM, Zulet MA, Puchau B, Martínez JA. Central adiposity rather than total adiposity measurements are specifically involved in the inflammatory status from healthy young adults. Inflammation. 2011;34(3):161-70. https://doi.org/10.1007/s10753-010-9219-y PMID:20467889
Martinez-Gomez D, Eisenmann JC, Warnberg J, Gomez-Martinez S, Veses A, Veiga OL, Marcos A; AFINOS Study Group. Associations of physical activity, cardiorespiratory fitness and fatness with low-grade inflammation in adolescents: the AFINOS Study. Int J Obes (Lond). 2010;34:1501-7. https://doi.org/10.1038/ijo.2010.114 - PMID:20531354
Kanneganti TD, Dixit VD. Immunological complications of obesity. Nat Immunol. 2012;13(8):707-12. https://doi.org/10.1038/ni.2343 - PMID:22814340
Yang H, Youm YH, Vandanmagsar B, Ravussin A, Gimble JM, Greenway F, Stephens JM, Mynatt RL, Dixit VD. Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. J Immunol. 2010;185(3):1836-45. https://doi.org/10.4049/jimmunol.1000021 PMID:20581149 - PMCID:PMC4829921
Winer DA, Winer S, Shen L, Wadia PP, Yantha J, Paltser G, Tsui H, Wu P, Davidson MG, Alonso MN, Leong HX, Glassford A, Caimol M, Kenkel JA, Tedder TF, McLaughlin T, Miklos DB, Dosch HM, Engleman EG. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med. 2011;17(5):610-7. https://doi.org/10.1038/nm.2353 PMID:21499269 - PMCID:PMC3270885
Osborn O, Olefsky JM. The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med. 2012;18(3):363-74. https://doi.org/10.1038/nm.2627 PMID:22395709
O'Rourke RW, Metcalf MD, White AE, Madala A, Winters BR, Maizlin II, Jobe BA, Roberts CT Jr, Slifka MK, Marks DL. Depot-specific differences in inflammatory mediators and a role for NK cells and IFN-gamma in inflammation in human adipose tissue. Int J Obes (Lond). 2009;33:978-90. https://doi.org/10.1038/ijo.2009.133 - PMID:19564875 - PMCID:PMC3150185
Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Nayer A, Lee J, Goldfine AB, Benoist C, Shoelson S, Mathis D. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med. 2009;15(8):930-9. https://doi.org/10.1038/nm.2002 - PMID:19633656 - PMCID:PMC3115752
Troubat R, Barone P, Leman S, Desmidt T, Cressant A, Atanasova B, Brizard B, Hage WE, Surget A, Belzung C, Camus V. Neuroinflammation and depression : a review. Eur J Neurosci. 2021;53(1):151-71. https://doi.org/10.1111/ejn.14720 - PMID:32150310
Moreno FA, Parkinson D, Palmer C, Castro WL, Misiaszek J, El Khoury A, Mathé AA, Wright R, Delgado PL. CSF neurochemicals during tryptophan depletion in individuals with remitted depression and healthy controls. Eur Neuropsychopharmacol. 2010;20(1):18-24. https://doi.org/10.1016/j.euroneuro.2009.10.003 - PMID:19896342 - PMCID:PMC2794896
O'Connor JC, André C, Wang Y, Lawson MA, Szegedi SS, Lestage J, Castanon N, Kelley KW, Dantzer R. Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus calmette-guerin. J Neurosci. 2009;29(13):4200-9. https://doi.org/10.1523/JNEUROSCI.5032-08.2009 - PMID:19339614 - PMCID:PMC2835569
Badawy AAB. Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects. Int J Tryptophan Res. 2017;10:1-20. https://doi.org/10.1177/1178646917691938 PMID:28469468 - PMCID:PMC5398323
Capuron L, Miller AH. Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther. 2011;130(2):226-38. https://doi.org/10.1016/j.pharmthera.2011.01.014 - PMID:21334376 - PMCID:PMC3072299
Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9:46-56. https://doi.org/10.1038/nrn2297 - PMID:18073775 - PMCID:PMC2919277
O'Connor JC, Lawson MA, André C, Briley EM, Szegedi SS, Lestage J, Castanon N, Herkenham M, Dantzer R, Kelley KW. Induction of IDO by bacille calmette-guérin is responsible for development of murine depressive-like behavior. J Immunol. 2009;182(5):3202-12. https://doi.org/10.4049/jimmunol.0802722 - PMID:19234218 - PMCID:PMC2664258
Benros ME, Waltoft BL, Nordentoft M, Ostergaard SD, Eaton WW, Krogh J, Mortensen PB. Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study. JAMA Psychiatry. 2013;70(8):812-20. https://doi.org/10.1001/jamapsychiatry.2013.1111 PMID:23760347
Benatti C, Blom JMC, Rigillo G, Alboni S, Zizzi F, Torta R, Brunello N, Tascedda F. Disease-induced neuroinflammation and depression. CNS Neurol Disord Drug Targets. 2016;15(4):414-33. https://doi.org/10.2174/1871527315666160321104749 - PMID:26996176
McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev. 2007;87(3):873-904. https://doi.org/10.1152/physrev.00041.2006 - PMID:17615391
Wester VL, Staufenbiel SM, Veldhorst MAB, Visser JA, Manenschijn L, Koper JW, Klessens-Godfroy FJM, van den Akker ELT, van Rossum EFC. Long-term cortisol levels measured in scalp hair of obese patients. Obesity (Silver Spring). 2014;22(9):1956-8. https://doi.org/10.1002/oby.20795 - PMID:24852462
Milaneschi Y, Simmons WK, van Rossum EFC, Penninx BW. Depression and obesity : evidence of shared biological mechanisms. Mol Psychiatry. 2019;24:18-33. https://doi.org/10.1038/s41380-018-0017-5 - PMID:29453413
Juruena MF, Cleare AJ. Superposição entre depressão atípica, doença afetiva sazonal e síndrome da fadiga crônica. Rev Bras Psiquiatr. 2007;29 Suppl 1:S19-26. https://doi.org/10.1590/S1516-44462007000500005 - PMID:17546343
Milaneschi Y, Lamers F, Peyrot WJ, Baune BT, Breen G, Dehghan A, Forstner AJ, Grabe HJ, Homuth G, Kan C, Lewis C, Mullins N, Nauck M, Pistis G, Preisig M, Rivera M, Rietschel M, Streit F, Strohmaier J, Teumer A, Van der Auwera S, Wray NR, Boomsma DI, Penninx BWJH; CHARGE Inflammation Working Group and the Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium. Genetic association of major depression with atypical features and obesity-related immunometabolic dysregulations. JAMA Psychiatry. 2017;74(12):1214-25. https://doi.org/10.1001/jamapsychiatry.2017.3016 - PMID:29049554 - PMCID:PMC6396812
Yoon HK, Kim YK, Lee HJ, Kwon DY, Kim L. Role of cytokines in atypical depression. Nord J Psychiatry. 2012;66(3):183-8. https://doi.org/10.3109/08039488.2011.611894 - PMID:21936732
Xu Q, Anderson D, Lurie-Beck J. The relationship between abdominal obesity and depression in the general population: a systematic review and meta-analysis. Obes Res Clin Pract. 2011;5(4):e267-78. https://doi.org/10.1016/j.orcp.2011.04.007 - PMID:24331129
Hickman RJ, Khambaty T, Stewart JC. C-reactive protein is elevated in atypical but not nonatypical depression: data from the National Health and Nutrition Examination survey (NHANES) 1999-2004. J Behav Med. 2014;37:621-9. https://doi.org/10.1007/s10865-013-9510-0 PMID:23624671
Kappelmann N, Arloth J, Georgakis MK, Czamara D, Rost N, Ligthart S, Khandaker GM, Binder EB. Dissecting the association between inflammation, metabolic dysregulation, and specific depressive symptoms: a genetic correlation and 2-sample mendelian randomization study. JAMA Psychiatry. 2021;78(2):161-70. https://doi.org/10.1001/jamapsychiatry.2020.3436 - PMID:33079133 PMCID:PMC7577200
Iwata M, Ota KT, Duman RS. The inflammasome: pathways linking psychological stress, depression, and systemic illnesses. Brain Behav Immun. 2013;31:105-14. https://doi.org/10.1016/j.bbi.2012.12.008 - PMID:23261775 - PMCID:PMC4426992
Wong ML, Inserra A, Lewis MD, Mastronardi CA, Leong L, Choo J, Kentish S, Xie P, Morrison M, Wesselingh SL, Rogers GB, Licinio J. Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition. Mol Psychiatry. 2016;21:797-805. https://doi.org/10.1038/mp.2016.46 - PMID:27090302 - PMCID:PMC4879188
Yin Z, Deng T, Peterson LE, Yu R, Lin J, Hamilton DJ, Reardon PR, Sherman V, Winnier GE, Zhan M, Lyon CJ, Wong STC, Hsueh WA. Transcriptome analysis of human adipocytes implicates the NOD-like receptor pathway in obesity-induced adipose inflammation. Mol Cell Endocrinol. 2014;394(1-2):80-7. https://doi.org/10.1016/j.mce.2014.06.018 - PMID:25011057 PMCID:PMC4219530
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2023 Tainá Patrícia Teixeira Bezerra, Roberto Mendes dos Santos , Alfredo José Minervino, Naiara Naiana Dejani
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial 4.0.
Debates em Psiquiatria permite que el (los) autor (es) mantenga(n) sus derechos de autor sin restricciones. Permite al (los) autor (es) conservar sus derechos de publicación sin restricciones. Los autores deben garantizar que el artículo es un trabajo original sin fabricación, fraude o plagio; no infringe ningún derecho de autor o derecho de propiedad de terceros. Los autores también deben garantizar que cada uno atendió a los requisitos de autoría conforme a la recomendación del ICMJE y entienden que, si el artículo o parte de él es fallido o fraudulento, cada autor comparte la responsabilidad.
Reconocimiento-NoComercial 4.0 internacional (CC BY-NC 4.0) - Debates em Psiquiatria es regida por la licencia CC-BY-NC
Usted es libre de:
- Compartir — copiar y redistribuir el material en cualquier medio o formato
- Adaptar — remezclar, transformar y crear a partir del material
El licenciador no puede revocar estas libertades mientras cumpla con los términos de la licencia. Bajo las condiciones siguientes:
- Reconocimiento — Debe reconocer adecuadamente la autoría, proporcionar un enlace a la licencia e indicar si se han realizado cambios<. Puede hacerlo de cualquier manera razonable, pero no de una manera que sugiera que tiene el apoyo del licenciador o lo recibe por el uso que hace.
- NoComercial — No puede utilizar el material para una finalidad comercial.
No hay restricciones adicionales — No puede aplicar términos legales o medidas tecnológicas que legalmente restrinjan realizar aquello que la licencia permite.
